Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Health-related Quality of Life in Women with Breast Cancer: a Literature-based Review of Psychometric Properties of Breast Cancer-specific Measures

  • Niu, Hui-Yan (Department of Geriatrics, Shengjing Hospital, China Medical University) ;
  • Niu, Chun-Ying (School of Public Health, University of Alberta) ;
  • Wang, Jia-He (Department of Geriatrics, Shengjing Hospital, China Medical University) ;
  • Zhang, Yi (Department of Geriatrics, Shengjing Hospital, China Medical University) ;
  • He, Ping (Department of Geriatrics, Shengjing Hospital, China Medical University)
  • Published : 2014.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Breast cancer is one of the most common cancers in women in the world. Health-related quality of life (HRQL) at treatment endpoint in cancer clinical trials is widely considered to be increasingly important. The aim of this review was to provide a literature-based assessment of the validity, reliability and responsiveness of breast cancer-specific HRQL instruments in women breast cancer patients. Materials and Methods: The databases consulted were Medline, PubMed, and Embase. The inclusion criteria required studies to: (1) involve use of HRQL measures; (2) cover women with breast cancer under standard treatment (surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy); (3) involve the validity, reliability, or responsiveness of HRQL; (4) deal with validation of breast cancer-specific HRQL instruments. Results: A total of 16 studies were identified through the literature search that met the 4 inclusion criteria. Some seven instruments were assessed among these 16 studies: EORTC QLQ-BR23, FACT-B, FACT-ES, HFRDIS, LSQ-32, QLICP-BR, and SLDS-BC. EORTC QLQ-BR23, FACT-B, LSQ-32, QLICP-BR, and SLDS-BC are more general breast cancer-specific HRQL instruments. FACT-EB is the endocrine subscale combined with FACT-B in order to measure the side effects and putative benefits of hormonal treatment administered in breast cancer patients. HFRDIS is the HRQL measure focusing on hot flash concerns. Conclusions: This paper provides an overall understanding on the currently available breast cancer-specific HRQL instruments in women breast cancer patients.

Keywords

References

  1. Ahmad Kiadaliri A, Bastani P, Ibrahimipour H (2012). Healthrelated quality of life of breast cancer patients in Iran: pooled analysis using generalized estimating equations. Asian Pac J Cancer Prev, 13, 941-4. https://doi.org/10.7314/APJCP.2012.13.3.941
  2. Brady MJ, Cella DF, Mo F, et al (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15, 974-86.
  3. Carlsson M, Hamrin E (1996). Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30. Qual Life Res, 5, 265-74. https://doi.org/10.1007/BF00434748
  4. Carpenter JS (2001). The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage, 22, 979-89. https://doi.org/10.1016/S0885-3924(01)00353-0
  5. Carpenter JS, Andrykowski MA, Cordova M, et al (1998). Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer, 82, 1682-91. https://doi.org/10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO;2-0
  6. Cerezo O, Onate-Ocana LF, Arrieta-Joffe P, et al (2012). Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. Eur J Cancer Care (Engl), 21, 684-91. https://doi.org/10.1111/j.1365-2354.2012.01336.x
  7. Chie WC, Chang KJ, Huang CS, et al (2003). Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psychooncology, 12, 729-35. https://doi.org/10.1002/pon.727
  8. Couzi RJ, Helzlsouer KJ, Fetting JH (1995). Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol, 13, 2737-44.
  9. Fallowfield LJ, Leaity SK, Howell A, et al (1999). Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat, 55, 189-99.
  10. Ganz PA, Desmond KA, Leedham B, et al (2002). Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst, 94, 39-49. https://doi.org/10.1093/jnci/94.1.39
  11. Goodwin PJ, Black JT, Bordeleau LJ, et al (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock. J Natl Cancer Inst, 95, 263-81. https://doi.org/10.1093/jnci/95.4.263
  12. Jayasekara H, Rajapaksa LC, Brandberg Y (2008). Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23. Qual Life Res, 17, 927-32. https://doi.org/10.1007/s11136-008-9359-9
  13. Lemieux J, Goodwin PJ, Bordeleau LJ, et al (2011). Qualityof-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009). J Natl Cancer Inst, 103, 178-231. https://doi.org/10.1093/jnci/djq508
  14. Mohammadi S, Sulaiman S, Koon PB, et al (2013). Association of nutritional status with quality of life in breast cancer survivors. Asian Pac J Cancer Prev, 14, 7749-55. https://doi.org/10.7314/APJCP.2013.14.12.7749
  15. Montazeri A (2008). Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res, 27, 32. https://doi.org/10.1186/1756-9966-27-32
  16. Montazeri A, Gillis CR, McEwen J (1996). Measuring quality of life in oncology: is it worthwhile? I. Meaning, purposes and controversies. Eur J Cancer Care (Engl), 5, 159-67. https://doi.org/10.1111/j.1365-2354.1996.tb00228.x
  17. Montazeri A, Harirchi I, Vahdani M, et al (2000). The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res, 9, 177-84. https://doi.org/10.1023/A:1008918310251
  18. Munoz M (2010). Quality of life during treatment in young women with breast cancer. Breast Cancer Res Treat, 123, 75-7. https://doi.org/10.1007/s10549-010-1061-2
  19. Ng R, Lee CF, Wong NS, et al (2012). Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients. Breast Cancer Res Treat, 131, 619-25. https://doi.org/10.1007/s10549-011-1764-z
  20. Pandey M, Thomas BC, Ramdas K, et al (2002). Quality of life in breast cancer patients: validation of a FACT-B Malayalam version. Qual Life Res, 11, 87-90. https://doi.org/10.1023/A:1015083713014
  21. Scholtes VA, Terwee CB, Poolman RW (2011). What makes a measurement instrument valid and reliable? Injury, 42, 236-40. https://doi.org/10.1016/j.injury.2010.11.042
  22. Spagnola S, Zabora J, BrintzenhofeSzoc K, et al (2003). The Satisfaction with Life Domains Scale for Breast Cancer (SLDS-BC). Breast J, 9, 463-71. https://doi.org/10.1046/j.1524-4741.2003.09603.x
  23. Sprangers MA, Groenvold M, Arraras JI, et al (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14, 2756-68.
  24. Terwee CB, Bot SD, de Boer MR, et al (2007). Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol, 60, 34-42. https://doi.org/10.1016/j.jclinepi.2006.03.012
  25. Wan C, Tang X, Tu XM, et al (2007a). Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients. Breast Cancer Res Treat, 105, 187-93. https://doi.org/10.1007/s10549-006-9443-1
  26. Wan C, Yang Z, Tang X, et al (2009). Development and validation of the system of quality of life instruments for cancer patients: breast cancer (QLICP-BR). Support Care Cancer, 17, 359-66. https://doi.org/10.1007/s00520-008-0478-1
  27. Wan C, Zhang D, Yang Z, et al (2007b). Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat, 106, 413-8. https://doi.org/10.1007/s10549-007-9511-1
  28. Whelan TJ, Goss PE, Ingle JN, et al (2005). Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol, 23, 6931-40. https://doi.org/10.1200/JCO.2005.11.181
  29. Whelan TJ, Pritchard KI (2006). Managing patients on endocrine therapy: focus on quality-of-life issues. Clin Cancer Res, 12, 1056-60. https://doi.org/10.1158/1078-0432.CCR-05-2185
  30. Yun YH, Bae SH, Kang IO, et al (2004). Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). Support Care Cancer, 12, 441-5. https://doi.org/10.1007/s00520-004-0632-3

Cited by

  1. Post-traumatic Stress Disorder and Post-traumatic Growth in Breast Cancer Patients - a Systematic Review vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.641
  2. The quality of systematic reviews of health-related outcome measurement instruments vol.25, pp.4, 2016, https://doi.org/10.1007/s11136-015-1122-4